AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-106009829/after-close-point.html" title="Facts and information about AFTER THE CLOSE.(TO THE POINT)">AFTER THE CLOSE.(TO THE POINT)</a>
Close
Set up an RSS feed that alerts you when new articles from Investor's Business Daily are available.
Frequently asked questions about RSS feeds
AFTER THE CLOSE.(TO THE POINT)
BEAZER HOMES' Feb. home orders rose 0.7% to 1,071.
THE FDA OK'd Thoratec's HeartMate VE pumping device to treat an expanded pool of patients.
PACIFIC SUNWEAR said Q4 net was flat at 43 cents, or 2 cents over analyst estimates.
FIRST HORIZON PHARMA earned 14 cents, up 75% and 2 cents over Q4 views. Sales grew 109%.
AMERICA WEST'S Feb. load factor rose 1.6 points to 69.3%.
HUMANA now sees $1.15-$1.19 in '02 vs. ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Landmark Rematch Trial Demonstrates Improved Survival Rates And Quality of Life...
- Press release article from: PR Newswire November 12, 2001 700+ words
...supported by Thoratec Corporation's HeartMate VE LVAS (left ventricular assist system...compared patients randomized to the HeartMate VE with those treated with optimal medical...one-year survival for those on the HeartMate VE was 52 percent versus 25 percent for...
- Texas Heart patient supports use of Thoratec HeartMate VE.
- Newspaper article from: Medical Device Daily March 14, 2002 700+ words
...Heart patient supports use of Thoratec HeartMate VE By DON LONG Medical Device Daily Managing...Texas) to testify to the value of the HeartMate VE ventricular assist device made by Thoratec...recommending FDA clearance of the HeartMate VE (Medical Device Daily, March 5, 2002...
- Thoratec gets 'destination therapy' nod for HeartMate VE.
- Newspaper article from: Medical Device Daily November 8, 2002 700+ words
...Thoratec gets destination therapy nod for HeartMate VE By HOLLAND JOHNSON Medical Device Daily...Thoratec said the FDA approved its HeartMate VE left ventricular assist system (LVAS...68 patients were implanted with the HeartMate VE and 61 were treated medically. Grossman...
- Earnings roundup.
- Newspaper article from: Medical Device Daily July 26, 2002 700+ words
...5 million or 62 cents a share from $79.2 million or 41 cents a share in the same...of $556,000 or 1 cent a share, down sharply...3.1 million or 6 cents a share in the comparable...features use of Thoratecs HeartMate VE device. Another cardiovascular...
- Thoratec eyes reimbursement hike for VADs as sales boost.
- Newspaper article from: Medical Device Daily August 4, 2004 700+ words
...The company received that approval in November 2002 for its HeartMate VE, with the XVE device garnering a clearance via a PMA supplement...the stock closed at $9.99 a share, down 1.28% or 13 cents a share despite the positive reimbursement news, as many investors...
- FDA panel nod only part of the battle facing companies.
- Newspaper article from: Medical Device Daily March 7, 2002 700+ words
...the stock of Thoratec (Pleasanton, California), whose HeartMate VE cardiac pump was recommended for approval on Monday by the...Wednesday afternoon, it had climbed back to $12.30, gaining 82 cents from the days opening price. For Medtronic, its stock dropped...
- Thoratec HeartMate(R) LVAS Cited Among the Year's Most Important Heart Failure...
- Press release article from: PR Newswire January 3, 2002 700+ words
...a medical device company, said its HeartMate VE LVAS (left ventricular assist system...failure patients implanted with the HeartMate VE LVAS lived longer and had a better quality...potentially significant role that the HeartMate VE LVAS may play in providing permanent...
- HeartMate LVAS gets panel nod for 'no option' patients.
- Newspaper article from: Medical Device Daily March 5, 2002 700+ words
...Thoratecs (Pleasanton, California) HeartMate VE LVAS (left ventricular assist system...decision on regulatory approval. The HeartMate VE has been on the market since 1998 for...premarket approval supplement, the HeartMate VE LVAS will be the only proven alternative...